Anemia Drug Side Effects: FDA Investigates Epogen, Aranesp and Procrit

The Food and Drug Administration (FDA) is set to form an independent panel of experts to re-evaluate the safety of three major anemia drugs: Epogen, Aranesp and Procrit. Agency officials say they expect to release new dosage and warning labels over the next several months.

The FDA decision comes one month after a recent study raised major safety concerns, indicating that the anemia drugs — sold by Amgen and Johnson & Johnson — may double the risk of stroke and heart attack at current dosage levels.

Epogen, Aranesp and Procrit Side Effects

Epogen, Aranesp and Procrit are frequently prescribed to patients suffering from diabetes and chronic kidney disease. The popular anemia drugs also are commonly prescribed to cancer patients following chemotherapy treatments. In addition, the study indicates that the drugs may worsen the survival rate of certain cancer patients.

The FDA panel is set to re-evaluate whether patients should be given lower doses of anemia drugs and how this may help decrease current health risks associated with Epogen, Aranesp and Procrit.

In the meantime, the sales of anemia drugs continue to decline, while Amgen claims the clinical trials are based on lack of understanding on how anemia drugs work. In addition, both drug companies have admitted paying millions of dollars to doctors in return for prescribing their patients anemia medicine. The total amount of payments has yet to be disclosed by Amgen and Johnson & Johnson, as the FDA prepares to further investigate the safety of all three drugs.

Anemia drug users are advised to discuss their options with their physician to determine the best course of action.

Anemia Drug Lawsuits

If you or a loved one has been injured as a result of treatment with an anemia drug such as Epogen, Aranesp or Procrit, you may be entitled to receive compensation. The defective anemia drug lawyers of Aylstock, Witkin, Kreis and Overholtz are among the leading personal injury attorneys in Florida who have settled a number of defective drug cases. Contact the AWKO team at (888) 255 – 2956 to learn whether you have a valid claim against a drug manufacturer as a victim of anemia drug injury.